COVID-19 treatment: Steroids may improve survival rate of critically ill patients, study says

Covid-19 treatment
Steroids may improve survival rate of critically ill patients

Some recent studies, as published by the Journal of the American Medical Association, have shown that multiple types of steroids improve survival for severely ill COVID-19 patients.

Results from seven studies, led by the World Health Organisation, found that steroids reduced the risk of death in the first month by about one-third compared to placebo treatment or usual care alone in these seriously ill patients who needed extra oxygen.

“This result opens up more choices” of steroids, said Dr. Martin Landray of the University of Oxford, who led one of the studies. “The more options there are in terms of availability, the better.” 

Dr. Anthony Gordon of Imperial College London called the result “a huge step forward,” but added, “as impressive as these results are, it’s not a cure.” 

Steroid drugs are inexpensive, widely available and have been used for decades. They reduce inflammation, which sometimes develops in coronavirus patients as the immune system overreacts to fight the infection. This overreaction damages the lungs and can prove fatal. These drugs are not the same type of steroids that are used or misused for athletic performance.

In June, a large study led by the University of Oxford found that a steroid called dexamethasone cut deaths by up to 35% in hospitalized COVID-19 patients who needed treatment with breathing machines and by 20% in those only needing extra oxygen. It did not help less sick patients and might even have even been harmful at that stage of illness.

The results changed care immediately and prompted many other studies that were testing steroids to stop, so more people could be given the drug. The new analysis looked at results from six of those studies that were stopped early plus severe patients in the Oxford study to see if all types of steroids were similarly effective, and concluded they are.

There were 222 deaths among the 678 patients given a steroid and 425 deaths among the 1,025 patients given placebos or just usual care.

“I’m delighted,” said Dr. Derek Angus, critical care chief at the University of Pittsburgh Medical Center, who helped lead one of the studies. “It’s incredibly reassuring that the other trials all were lining up in the same direction. It’s the most solid news we’ve had yet on how to take care of patients with COVID-19.” 

Currently, treatment guidelines in the US recommend dexamethasone or others only when it’s not available for hospitalized COVID-19 patients needing extra oxygen, but that could change with the new information.

Also Read: Covid-19 treatment: Dexamethasone can help fight coronavirus and prevent deaths, here’s all you need to know

Also Read: Immunizations during the Covid-19 pandemic


  1. […] The re-colourized images show infected ciliated cells with strands of mucus (yellow) attached to cilia tips (blue). Cilia are the hair-like structures on the surface of airway epithelial cells that transport mucus (and trapped viruses) from the lung. A higher power magnification image shows the structure and density of SARS-CoV-2 virions (red) produced by human airway epithelia. Virions are the complete, infectious form of the coronavirus released onto respiratory surfaces by infected host cells.Also Read: COVID-19 treatment: Steroids may improve survival rate of critically ill patients, study … […]

  2. […] While traveling, we should be cautious of any public transportation. If you are going to have to use an airplane or train, the most important thing is not just wearing a mask, but considering eye protection, too. This can include face shields, glasses or goggles, and generally avoiding touching your eyes or face.Also Read: COVID-19 treatment: Steroids may improve survival rate of critically ill patients, study … […]


Please enter your comment!
Please enter your name here